Dennys Reyes
Cleveland Clinic
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Dennys Reyes.
Journal of Clinical Neuroscience | 2014
Dennys Reyes; Kateryna Kurako; Nestor Galvez-Jimenez
Impulse control disorders (ICD) are increasingly recognized in patients with Parkinsons disease (PD), particularly when treated with commonly used dopamine agonists such as pramipexole and ropinirole. Less evident is the possible association between monoamine oxidase inhibitors type B (MAO-B) and the development of ICD. Rasagiline is a second generation MAO-B I inducing moderate symptomatic and possibly disease modifying benefits with apparently good tolerability and safety profile in PD patients. Rasagiline is effective and well tolerated in PD as a monotherapy or in combination with levodopa. Here, we report a patient with PD who developed ICD when treated de novo with MAO-B inhibitors.
Journal of Clinical Neuroscience | 2015
Dennys Reyes; Richard A. Prayson
Tuberous sclerosis is an autosomal dominant condition commonly manifesting with seizures, mental retardation, cortical tubers and hamartomas. Neoplasms may occasionally arise in this setting with the majority of these tumors being subependymal giant cell astrocytomas (World Health Organization [WHO] grade I). Reports of high grade astrocytic neoplasms arising in patients with tuberous sclerosis are rare. We report a left fronto-parietal mass presenting in a 33-year-old woman with altered mental status and slurred speech. The tumor demonstrated areas of enhancement and was associated with mass effect on CT imaging. The tumor was marked by prominent cellularity, easily identifiable mitotic figures, vascular proliferative changes, necrosis and multinucleated giant cells. A Ki-67 labeling index of greater than 30% was noted. The findings were interpreted as being consistent with a glioblastoma (WHO grade IV). The limited literature on similar cases of malignant gliomas arising in the setting of tuberous sclerosis are reviewed. Few reports of similar tumors have been described in the literature. Presentation appears to depend on where the tumor is situated; locations have been variable in previous reports. For those cases in which survival data were included, the prognosis is poor.
Parkinson's Disease | 2017
Hesham Abboud; Gencer Genc; Nicolas R. Thompson; Srivadee Oravivattanakul; Faisal Alsallom; Dennys Reyes; Kathy Wilson; Russell Cerejo; Xin Xin Yu; Darlene Floden; Anwar Ahmed; Michal Gostkowski; Ayman Ezzeldin; Hazem Marouf; Ossama Y. Mansour; Andre G. Machado; Hubert H. Fernandez
Objective The primary objective was to evaluate predictors of quality of life (QOL) and functional outcomes following deep brain stimulation (DBS) in Parkinsons disease (PD) patients. The secondary objective was to identify predictors of global improvement. Methods PD patients who underwent DBS at our Center from 2006 to 2011 were evaluated by chart review and email/phone survey. Postoperative UPDRS II and EQ-5D were analyzed using simple linear regression adjusting for preoperative score. For global outcomes, we utilized the Patient Global Impression of Change Scale (PGIS) and the Clinician Global Impression of Change Scale (CGIS). Results There were 130 patients in the dataset. Preoperative and postoperative UPDRS II and EQ-5D were available for 45 patients, PGIS for 67 patients, and CGIS for 116 patients. Patients with falls/postural instability had 6-month functional scores and 1-year QOL scores that were significantly worse than patients without falls/postural instability. For every 1-point increase in preoperative UPDRS III and for every 1-unit increase in body mass index (BMI), the 6-month functional scores significantly worsened. Patients with tremors, without dyskinesia, and without gait-freezing were more likely to have “much” or “very much” improved CGIS. Conclusions Presence of postural instability, high BMI, and worse baseline motor scores were the greatest predictors of poorer functional and QOL outcomes after DBS.
The Spine Journal | 2013
Dennys Reyes; Fabian J. Candocia
BACKGROUND Angiolipomas are rare benign tumors, accounting for 0.14% to 1.2% of all tumors of the spinal axis with vascular and fatty histological features. Spinal angiolipoma (SAL) is most commonly found in the thoracic region and has high signal on contrast enhanced fat-saturated T1-weighted imaging. Although the international literature is extensive, there are few cases reported in United States. OBJECTIVE To present a case of SAL located in the thoracolumbar region without high signal on contrast enhanced fat-saturated T1-weighted imaging and to review previously reported cases. STUDY DESIGN/METHODS Case report and review the literature. RESULTS Magnetic resonance imaging obtained in a 68-year-old man with a long history of lumbago showed a heterogeneous mass (T10-L1) hyperintense on T1-weighted imaging but not enhancing on suppression fat sequences, suggesting epidural hematoma. Surgical excision of the lesion was performed, and SAL was diagnosed and confirmed by pathology. The patient became asymptomatic. CONCLUSIONS The predominance of either vascular or fatty components inside the tumor might alter the expected results on magnetic resonance imaging with suppression fat sequences.
Neurology | 2016
Pirouz Piran; Alex Linn; Dennys Reyes; Subin Mathew; James Benjamin Gleason; Tarannum Khan
Neurology | 2016
Dennys Reyes; Lixandra Gonzalez; Pirouz Piran; Subin Mathew; Alex Linn; Samer Riaz; Raja Boddepalli; Efrain Salgado
Neurology | 2016
Lixandra Gonzalez; Dennys Reyes; Pirouz Piran; Subin Mathew; Alex Linn; Efrain Salgado
Neurology | 2016
Dennys Reyes; Lixandra Gonzalez; Samer Riaz; Raja Boddepalli; Subin Mathew; Pirouz Piran; Alex Linn; Efrain Salgado
Neurology | 2015
Raja Boddepalli; Dennys Reyes; Efrain Salgado; Fabian J. Candocia; Rachana Gandhi; Avi Oppenheimer.
Neurology | 2015
Dennys Reyes; Hesham Abboud; Gencer Genc; Andre G. Machado; Scott E. Cooper; Michal Gostkowski; Hubert H. Fernandez